Copyright Reports & Markets. All rights reserved.

Global and United States Automated Drug Compounding Systems Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Automated Drug Compounding Systems Product Introduction
    • 1.2 Global Automated Drug Compounding Systems Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Automated Drug Compounding Systems Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Automated Drug Compounding Systems Sales in Volume for the Year 2017-2028
    • 1.3 United States Automated Drug Compounding Systems Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Automated Drug Compounding Systems Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Automated Drug Compounding Systems Sales in Volume for the Year 2017-2028
    • 1.4 Automated Drug Compounding Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Automated Drug Compounding Systems in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Automated Drug Compounding Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Automated Drug Compounding Systems Market Dynamics
      • 1.5.1 Automated Drug Compounding Systems Industry Trends
      • 1.5.2 Automated Drug Compounding Systems Market Drivers
      • 1.5.3 Automated Drug Compounding Systems Market Challenges
      • 1.5.4 Automated Drug Compounding Systems Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Automated Drug Compounding Systems Market Segment by Type
      • 2.1.1 Gravimetric Automated Compounding Systems
      • 2.1.2 Volumetric Automated Compounding Systems
    • 2.2 Global Automated Drug Compounding Systems Market Size by Type
      • 2.2.1 Global Automated Drug Compounding Systems Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Automated Drug Compounding Systems Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Automated Drug Compounding Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Automated Drug Compounding Systems Market Size by Type
      • 2.3.1 United States Automated Drug Compounding Systems Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Automated Drug Compounding Systems Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Automated Drug Compounding Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Automated Drug Compounding Systems Market Segment by Application
      • 3.1.1 Hospitals
      • 3.1.2 Chemotherapy Centers
      • 3.1.3 Others
    • 3.2 Global Automated Drug Compounding Systems Market Size by Application
      • 3.2.1 Global Automated Drug Compounding Systems Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Automated Drug Compounding Systems Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Automated Drug Compounding Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Automated Drug Compounding Systems Market Size by Application
      • 3.3.1 United States Automated Drug Compounding Systems Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Automated Drug Compounding Systems Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Automated Drug Compounding Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Automated Drug Compounding Systems Competitor Landscape by Company

    • 4.1 Global Automated Drug Compounding Systems Market Size by Company
      • 4.1.1 Top Global Automated Drug Compounding Systems Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Automated Drug Compounding Systems Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Automated Drug Compounding Systems Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Automated Drug Compounding Systems Price by Manufacturer (2017-2022)
    • 4.2 Global Automated Drug Compounding Systems Concentration Ratio (CR)
      • 4.2.1 Automated Drug Compounding Systems Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Automated Drug Compounding Systems in 2021
      • 4.2.3 Global Automated Drug Compounding Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Automated Drug Compounding Systems Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Automated Drug Compounding Systems Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Automated Drug Compounding Systems Product Type
      • 4.3.3 Date of International Manufacturers Enter into Automated Drug Compounding Systems Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Automated Drug Compounding Systems Market Size by Company
      • 4.5.1 Top Automated Drug Compounding Systems Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Automated Drug Compounding Systems Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Automated Drug Compounding Systems Sales by Players (2020, 2021 & 2022)

    5 Global Automated Drug Compounding Systems Market Size by Region

    • 5.1 Global Automated Drug Compounding Systems Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Automated Drug Compounding Systems Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Automated Drug Compounding Systems Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Automated Drug Compounding Systems Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Automated Drug Compounding Systems Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Automated Drug Compounding Systems Sales in Value by Region: 2017-2022
      • 5.3.2 Global Automated Drug Compounding Systems Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Automated Drug Compounding Systems Market Size YoY Growth 2017-2028
      • 6.1.2 North America Automated Drug Compounding Systems Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Automated Drug Compounding Systems Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Automated Drug Compounding Systems Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Automated Drug Compounding Systems Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Automated Drug Compounding Systems Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Automated Drug Compounding Systems Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Automated Drug Compounding Systems Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Automated Drug Compounding Systems Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Automated Drug Compounding Systems Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Baxter International Inc.
      • 7.1.1 Baxter International Inc. Corporation Information
      • 7.1.2 Baxter International Inc. Description and Business Overview
      • 7.1.3 Baxter International Inc. Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Baxter International Inc. Automated Drug Compounding Systems Products Offered
      • 7.1.5 Baxter International Inc. Recent Development
    • 7.2 Braun Melsungen AG
      • 7.2.1 Braun Melsungen AG Corporation Information
      • 7.2.2 Braun Melsungen AG Description and Business Overview
      • 7.2.3 Braun Melsungen AG Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Braun Melsungen AG Automated Drug Compounding Systems Products Offered
      • 7.2.5 Braun Melsungen AG Recent Development
    • 7.3 Comecer
      • 7.3.1 Comecer Corporation Information
      • 7.3.2 Comecer Description and Business Overview
      • 7.3.3 Comecer Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Comecer Automated Drug Compounding Systems Products Offered
      • 7.3.5 Comecer Recent Development
    • 7.4 ICU MEDICAL INC
      • 7.4.1 ICU MEDICAL INC Corporation Information
      • 7.4.2 ICU MEDICAL INC Description and Business Overview
      • 7.4.3 ICU MEDICAL INC Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 ICU MEDICAL INC Automated Drug Compounding Systems Products Offered
      • 7.4.5 ICU MEDICAL INC Recent Development
    • 7.5 Grifols, S.A.
      • 7.5.1 Grifols, S.A. Corporation Information
      • 7.5.2 Grifols, S.A. Description and Business Overview
      • 7.5.3 Grifols, S.A. Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Grifols, S.A. Automated Drug Compounding Systems Products Offered
      • 7.5.5 Grifols, S.A. Recent Development
    • 7.6 Omnicell
      • 7.6.1 Omnicell Corporation Information
      • 7.6.2 Omnicell Description and Business Overview
      • 7.6.3 Omnicell Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Omnicell Automated Drug Compounding Systems Products Offered
      • 7.6.5 Omnicell Recent Development
    • 7.7 Equashield
      • 7.7.1 Equashield Corporation Information
      • 7.7.2 Equashield Description and Business Overview
      • 7.7.3 Equashield Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Equashield Automated Drug Compounding Systems Products Offered
      • 7.7.5 Equashield Recent Development
    • 7.8 ARxIUM
      • 7.8.1 ARxIUM Corporation Information
      • 7.8.2 ARxIUM Description and Business Overview
      • 7.8.3 ARxIUM Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 ARxIUM Automated Drug Compounding Systems Products Offered
      • 7.8.5 ARxIUM Recent Development
    • 7.9 Weibond Technology
      • 7.9.1 Weibond Technology Corporation Information
      • 7.9.2 Weibond Technology Description and Business Overview
      • 7.9.3 Weibond Technology Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Weibond Technology Automated Drug Compounding Systems Products Offered
      • 7.9.5 Weibond Technology Recent Development
    • 7.10 NewIcon
      • 7.10.1 NewIcon Corporation Information
      • 7.10.2 NewIcon Description and Business Overview
      • 7.10.3 NewIcon Automated Drug Compounding Systems Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 NewIcon Automated Drug Compounding Systems Products Offered
      • 7.10.5 NewIcon Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Automated Drug Compounding Systems Industry Chain Analysis
    • 8.2 Automated Drug Compounding Systems Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Automated Drug Compounding Systems Distributors
    • 8.3 Automated Drug Compounding Systems Production Mode & Process
    • 8.4 Automated Drug Compounding Systems Sales and Marketing
      • 8.4.1 Automated Drug Compounding Systems Sales Channels
      • 8.4.2 Automated Drug Compounding Systems Distributors
    • 8.5 Automated Drug Compounding Systems Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated compounding system helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion while using similar labels. However, with the automated compounding systems, the accuracy and efficiency of dispensing compounded products have improved and reduced the exposure of healthcare professionals to toxic agents.
      Market Analysis and Insights: Global and United States Automated Drug Compounding Systems Market
      This report focuses on global and United States Automated Drug Compounding Systems market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Automated Drug Compounding Systems market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Gravimetric Automated Compounding Systems accounting for % of the Automated Drug Compounding Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Automated Drug Compounding Systems market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Automated Drug Compounding Systems Scope and Market Size
      Automated Drug Compounding Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Automated Drug Compounding Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Automated Drug Compounding Systems market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Automated Drug Compounding Systems market is segmented into
      Gravimetric Automated Compounding Systems
      Volumetric Automated Compounding Systems
      Segment by Application, the Automated Drug Compounding Systems market is segmented into
      Hospitals
      Chemotherapy Centers
      Others
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Automated Drug Compounding Systems Market Share Analysis
      Automated Drug Compounding Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Automated Drug Compounding Systems business, the date to enter into the Automated Drug Compounding Systems market, Automated Drug Compounding Systems product introduction, recent developments, etc.
      The major vendors covered:
      Baxter International Inc.
      Braun Melsungen AG
      Comecer
      ICU MEDICAL INC
      Grifols, S.A.
      Omnicell
      Equashield
      ARxIUM
      Weibond Technology
      NewIcon
      Buy now